Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.66EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.66EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JB.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.86.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.86.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JW.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1.6.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.19.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.19.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.479EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.479EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.437EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.437EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.371EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.371EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.6.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FY.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GS.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
BA.1.21.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.21.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.37EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.39EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EE.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DV.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ES.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ES.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.41EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used